SCHEMBL857587

SCHEMBL857587

CCCc1ncnc(N2CCOc3ccc(-c4ccc5nc(C)[nH]c5c4)cc3C2)c1CC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 12/20 0.47
USP7 Q93009 1/20 0.37
FGFR1 P11362 1/20 0.34
FGFR2 P21802 1/20 0.34
FGFR3 P22607 1/20 0.34
ALDH1A1 P00352 2/20 0.32
USP2 O75604 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPK1 P28482 1/20 0.32
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
KIT P10721 1/20 0.32
RPS6KB1 P23443 1/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL854559 0.94 PIK3CA (0.49) PIK3CAUSP7FGFR1FGFR2FGFR3
SCHEMBL855410 0.92 PIK3CA (0.48) PIK3CAUSP7FGFR1FGFR2FGFR3
SCHEMBL857336 0.90 PIK3CA (0.48) PIK3CAUSP7FGFR1FGFR2FGFR3
SCHEMBL856658 0.90 PIK3CA (0.49) PIK3CAUSP7FGFR1FGFR2FGFR3
SCHEMBL857920 0.88 PIK3CA (0.49) PIK3CAUSP7FGFR1FGFR2FGFR3
SCHEMBL857586 0.87 PIK3CA (0.47) PIK3CAUSP7FGFR1FGFR2FGFR3
SCHEMBL856572 0.86 PIK3CA (0.45) PIK3CAUSP7ALDH1A1KDM4ENPC1
SCHEMBL859214 0.83 PIK3CA (0.49) PIK3CAUSP7FGFR1FGFR2FGFR3
SCHEMBL859026 0.83 PIK3CA (0.52) PIK3CAFGFR1FGFR2FGFR3ALDH1A1
SCHEMBL858462 0.83 PIK3CA (0.47) PIK3CAUSP7FGFR1FGFR2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed
WO-2010135524-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2010-11-25 WO disclosed